Bledsoe, Adam C.
Garber, John J.
Ye, Weimin
Roelstraete, Bjorn
Murray, Joseph A.
Ludvigsson, Jonas F. http://orcid.org/0000-0003-1024-5602
Funding for this research was provided by:
Karolinska Institutet
Karolinska Institute
Article History
Received: 7 January 2022
Accepted: 28 June 2022
First Online: 19 July 2022
Declarations
:
: ACB: Nothing to disclose. JJG: Nothing to disclose. WY: Nothing to disclose. BR: Nothing to disclose. JAM: Dr. Joseph Murray has received study grants from Nexpep/ImmusanT, National Institutes of Health, Immunogenics, Johnson & Johnson, Kanyos/Anakion, Takeda Pharmaceutical, Allakos, Oberkotter, and Cour; consultancy fees from Bionix, UKKO, Dren Bio, Dr. Schar USA, Immunic, Chugai Pharma; holds patents licensed to Evelo Biosciences; and receives royalties from Torax Medical. JFL coordinates a study on behalf of the Swedish IBD quality register (SWIBREG). That study has received funding from the Janssen corporation.
: This project (2014/1287–31/4) was approved by the Research Ethics Committee in Stockholm, Sweden on August 27, 2014.